Company Analysis

Voyager Therapeutics, Inc. (VYGR)

Nasdaq: VYGR · Biological Products, (No Diagnostic Substances) · Lexington, MA · filing with the SEC since 2015
Grade5.4
◀ Past 6.1● Present 5.6▶ Future 4.3
1 est.

Who runs Voyager Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Higgins Michael J
Interim President & CEO. First filing Nov 2015, latest Jun 11, 2026, 1 filing in all.
Officers reporting now
9
of 16 people with a filing in the last fifteen months
Directors reporting now
7
32 people on the record since 2015
Officerssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Swartz RobinPresidentFeb 2022Nov 3, 20263 · $100,000
Carter Todd AlfredChief Scientific OfficerSep 2022Nov 3, 20263 · $0.00
Higgins Michael JInterim President & CEONov 2015Jun 11, 2026none
Pierce GlennInterim CSOJan 2017Jun 11, 2026none
Quinlan AmyPrincipal Accounting OfficerMay 2026May 18, 2026none
Sandrock AlfredPresident and CEOFeb 2022Apr 3, 20264 · $200,000
Shiferman Gregory L.SVP and General CounselJan 2026Apr 3, 2026none
Jorgensen Nathan D.Chief Financial OfficerJul 2024Feb 26, 20261 · $0.00
Ferguson TobyChief Medical OfficerMar 2024Feb 10, 2026none
Directorssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameRoleFirst filingLatest filingSales, 12 months
Colon GracedirectorJan 2023Jun 11, 2026none
Geraghty James AdirectorNov 2015Jun 11, 2026none
Hyman StevendirectorNov 2015Jun 11, 2026none
Mackey Catherine JdirectorAug 2022Jun 11, 2026none
Onyia JudedirectorFeb 2023Jun 11, 2026none
Scangos George AdirectorMay 2023Jun 11, 2026none
Vitale NancydirectorSep 2020Jun 11, 2026none
Earlier names on the record23, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton VYGR · research, not advice